RenX (SGD) faces Nasdaq $1.00 bid-price deficiency with cure deadline

Rhea-AI Filing Summary

RenX Enterprises Corp. reported that Nasdaq notified the company on January 26, 2026 that its common stock has failed to meet the minimum $1.00 per share closing bid price requirement for 30 consecutive business days, from December 5, 2025 through January 20, 2026.

The notice does not immediately affect trading, and the stock will continue to trade on The Nasdaq Capital Market under the symbol RENX. The company has 180 calendar days, until July 27, 2026, to regain compliance, which would occur if its closing bid price is at or above $1.00 for at least ten consecutive business days, subject to Nasdaq’s discretion to require a longer period.

If RenX does not regain compliance by that date, it may qualify for an additional compliance period if it meets other Nasdaq listing standards and submits a plan to cure the deficiency. The company states it will monitor its share price and may consider options such as a reverse stock split to maintain its Nasdaq listing.

Positive

• None.

Negative

• Nasdaq minimum bid-price deficiency: RenX’s common stock traded below the $1.00 required minimum closing bid for 30 consecutive business days, putting its Nasdaq Capital Market listing at risk if compliance is not regained.

Insights

Equity markets and listing standards analyst

RenX faces Nasdaq bid-price deficiency with a defined window to cure.

RenX Enterprises has received a Nasdaq notice that its stock closed below $1.00 for 30 consecutive business days, triggering a deficiency under Nasdaq Listing Rule 5550(a)(2). Trading continues on The Nasdaq Capital Market under the RENX symbol, so there is no immediate delisting.

The company has until July 27, 2026 to restore a closing bid at or above $1.00 for at least ten consecutive business days, though Nasdaq may require a longer streak before confirming compliance. Failure to meet this requirement could move the process toward delisting unless RenX qualifies for a second 180‑day period by meeting other initial listing standards and submitting an action plan.

RenX indicates it will monitor its share price and may consider a reverse stock split, which is a common mechanical tool to lift bid price without changing overall market value. Actual outcomes will depend on future share‑price performance and any corporate actions the company elects to pursue within the compliance periods.

false 0001959023 0001959023 2026-01-26 2026-01-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 26, 2026

RENX ENTERPRISES CORP.

(Exact Name of Registrant as Specified in its Charter)

Delaware		001-41581		87-1375590
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification Number)

100 Biscayne Blvd., #1201

Miami, FL 33132

(Address of Principal Executive Offices, Zip Code)

Registrant’s telephone number, including area code: (786) 808-5776

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common Stock, par value $0.001		RENX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On January 26, 2026, RenX Enterprises Corp. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (December 5, 2025 through January 20, 2026), the Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on The Nasdaq Capital Market under the symbol “RENX.”

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until July 27, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). Compliance may be achieved without further action if the closing bid price of the Company’s common stock is at or above $1.00 for a minimum of ten consecutive business days at any time during the 180-day compliance period, in which case Nasdaq will notify the Company if it determines it is in compliance and the matter will be closed; however Nasdaq may require the closing bid price to equal or to exceed the $1.00 minimum bid price requirement for more than 10 consecutive business days before determining that a company complies.

If, however, the Company does not achieve compliance with the Minimum Bid Price Requirement by July 27, 2026, the Company may be eligible for additional time to comply. In order to be eligible for such additional time, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and must notify Nasdaq in writing of its intention to cure the deficiency during the second compliance period.

The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the Nasdaq listing requirements, including such actions as effecting a reverse stock split to maintain its Nasdaq listing.

-1-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RENX ENTERPRISES CORP.
Dated: January 30, 2026
	By:	/s/ Nicolai Brune
	Name:	Nicolai Brune
	Title:	Chief Financial Officer

-2-

FAQ

What Nasdaq notice did RenX Enterprises Corp. receive in January 2026?

RenX Enterprises received a formal Nasdaq notice on January 26, 2026 stating its common stock failed to meet the $1.00 minimum closing bid price requirement for 30 consecutive business days, triggering a bid-price deficiency under Listing Rule 5550(a)(2).

Does the Nasdaq deficiency notice immediately affect trading in RenX (SGD) stock?

The notice has no immediate effect on trading. RenX’s common stock continues to trade on The Nasdaq Capital Market under the symbol RENX while the company works within the compliance period to restore its minimum $1.00 closing bid price.

How long does RenX have to regain Nasdaq bid-price compliance?

RenX has 180 calendar days, until July 27, 2026, to regain compliance. It must achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, subject to Nasdaq’s discretion to require a longer period.

What happens if RenX does not meet the $1.00 bid-price requirement by July 27, 2026?

If RenX does not regain compliance by July 27, 2026, it may still qualify for an additional 180‑day compliance period if it meets all other initial Nasdaq Capital Market listing standards and notifies Nasdaq in writing of a specific plan to cure the bid‑price deficiency.

What options is RenX considering to address the Nasdaq listing deficiency?

RenX states it will actively monitor its common stock’s bid price and consider available options to regain compliance with Nasdaq rules, including potentially effecting a reverse stock split, which can mechanically raise the share price without changing overall shareholder value.

What specific Nasdaq rule did RenX violate with its recent trading prices?

RenX fell out of compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum $1.00 per share closing bid price. Its shares closed below this threshold for 30 consecutive business days between December 5, 2025 and January 20, 2026.